Concepedia

Author

Pablo Cano

Sudbury Regional Hospital

Also Known As

CarlyA Buckner, P Cano, P. Cano, P. O. Cano, Pablo Cano, Pablo O. Cano, Pablo Oscar Cano

14

Publications

733

Citations

9

H-Index

27

Concepts

All Affiliations

Sudbury Regional HospitalLaurentian UniversityNortheast Cancer CentreNOSM UniversityUniversity of Ottawa
PC

About

Pablo Cano is an author at Sudbury Regional Hospital specializing in medicine, pharmacotherapy, and inflammation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

312

2

Immunology

3

3

213

3

Health Sciences

1

1

49

4

Allergy

1

1

87

5

Cell Biology

1

1

60

Pablo Cano

×

9

Publications

727

Citations

9

H-Index

YearCitations

PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy

Sharlene Gill, Yoo‐Joung Ko, C. Cripps,

Journal of Clinical Oncology

2016

282

Phase II Clinical Trial Results Involving Treatment with Low-Dose Daily Oral Cyclophosphamide, Weekly Vinblastine, and Rofecoxib in Patients with Advanced Solid Tumors

Scott D. Young, Mark Whissell, Jonathan Noble,

Clinical Cancer Research

2006

110

Stimulation of interleukin-1 and -6 production in alveolar macrophages by the neotropical liana, Uncaria tomentosa (Uña de Gato)

Irma Lemaire, Valerie Ann. Assinewe, Pablo Cano,

Journal of Ethnopharmacology

1999

87

Uncaria tomentosa acts as a potent TNF-α inhibitor through NF-κB

Lisa Allen-Hall, John T. Arnason, Pablo Cano,

Journal of Ethnopharmacology

2009

66

Treatment of THP-1 cells with Uncaria tomentosa extracts differentially regulates the expression if IL-1β and TNF-α

Lisa Allen-Hall, Pablo Cano, John T. Arnason,

Journal of Ethnopharmacology

2006

60

PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT).

Sharlene Gill, Yoo‐Joung Ko, M. Christine Cripps,

Journal of Clinical Oncology

2014

49

A 4-aminoquinoline derivative that markedly sensitizes tumor cell killing by Akt inhibitors with a minimum cytotoxicity to non-cancer cells

Changkun Hu, V. Raja Solomon, Pablo Cano,

European Journal of Medicinal Chemistry

2009

31

Recurrent renal cell cancer: 10 years or more after nephrectomy

Emmanuel O. Abara, Iolanda Chivulescu, Nilam Clerk,

Canadian Urological Association Journal

2013

23

A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer

Stefan Glück, Colin Germond, Pedro López,

European Journal of Cancer

1998

19

Page 1